OneCell Diagnostics is now 1Cell.Ai

Contact

1Cell ERA Newsletter | January 2026

The Jan 2026 edition of 1Cell.Ai Newsletter highlights key precision oncology trends including longitudinal liquid biopsy monitoring, clinical translation of single-cell technologies, and AI-driven decision support. It also features the launch of 1Cell.Ai’s NABL & CAP accredited Pune laboratory, the launch of new integrated NGS test OncoIndx® TBx and a real world lung cancer case

Download Newsletter
Close
1Cell.Ai
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.